These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30372586)

  • 1. Transplantation of HCV-infected organs into uninfected recipients: Advance with caution.
    Wadei HM; Pungpapong S; Cortese C; Alexander MP; Keaveny AP; Yang L; Taner CB; Croome KP
    Am J Transplant; 2019 Mar; 19(3):960-961. PubMed ID: 30372586
    [No Abstract]   [Full Text] [Related]  

  • 2. Liver transplantation for hepatitis C virus (HCV) non-viremic recipients with HCV viremic donors.
    Kwong AJ; Wall A; Melcher M; Wang U; Ahmed A; Subramanian A; Kwo PY
    Am J Transplant; 2019 May; 19(5):1380-1387. PubMed ID: 30378723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Center-level trends in utilization of HCV-exposed donors for HCV-uninfected kidney and liver transplant recipients in the United States.
    Bowring MG; Shaffer AA; Massie AB; Cameron A; Desai N; Sulkowski M; Garonzik-Wang J; Segev DL
    Am J Transplant; 2019 Aug; 19(8):2329-2341. PubMed ID: 30861279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of direct-acting antiviral agents on liver and kidney transplant costs and outcomes.
    Axelrod DA; Schnitzler MA; Alhamad T; Gordon F; Bloom RD; Hess GP; Xiao H; Nazzal M; Segev DL; Dharnidharka VR; Naik AS; Lam NN; Ouseph R; Kasiske BL; Durand CM; Lentine KL
    Am J Transplant; 2018 Oct; 18(10):2473-2482. PubMed ID: 29701909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplantation of kidneys from hepatitis C-infected donors to hepatitis C-negative recipients: Single center experience.
    Molnar MZ; Nair S; Cseprekal O; Yazawa M; Talwar M; Balaraman V; Podila PSB; Mas V; Maluf D; Helmick RA; Campos L; Nezakatgoo N; Eymard C; Horton P; Verma R; Jenkins AH; Handley CR; Snyder HS; Cummings C; Agbim UA; Maliakkal B; Satapathy SK; Eason JD
    Am J Transplant; 2019 Nov; 19(11):3046-3057. PubMed ID: 31306549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term outcomes of deceased donor renal transplants of HCV uninfected recipients from HCV seropositive nonviremic donors and viremic donors in the era of direct-acting antivirals.
    La Hoz RM; Sandıkçı B; Ariyamuthu VK; Tanriover B
    Am J Transplant; 2019 Nov; 19(11):3058-3070. PubMed ID: 31207073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Organs From Hepatitis C Virus-Positive Donors for Uninfected Recipients: A Potential Cost-Effective Approach to Save Lives?
    Trotter PB; Summers DM; Ushiro-Lumb I; Robb M; Bradley JA; Powell J; Watson CJE; Neuberger J
    Transplantation; 2018 Apr; 102(4):664-672. PubMed ID: 29166338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study.
    Manzardo C; Londoño MC; Castells L; Testillano M; Luis Montero J; Peñafiel J; Subirana M; Moreno A; Aguilera V; Luisa González-Diéguez M; Calvo-Pulido J; Xiol X; Salcedo M; Cuervas-Mons V; Manuel Sousa J; Suarez F; Serrano T; Ignacio Herrero J; Jiménez M; Fernandez JR; Giménez C; Del Campo S; Esteban-Mur JI; Crespo G; Moreno A; de la Rosa G; Rimola A; Miro JM;
    Am J Transplant; 2018 Oct; 18(10):2513-2522. PubMed ID: 29963780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should organs from hepatitis C-positive donors be used in hepatitis C-negative recipients for liver transplantation?
    Selzner N; Berenguer M
    Liver Transpl; 2018 Jun; 24(6):831-840. PubMed ID: 29624894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population level outcomes and cost-effectiveness of hepatitis C treatment pre- vs postkidney transplantation.
    Shelton BA; Sawinski D; Linas BP; Reese PP; Mustian M; Hungerpiller M; Reed RD; MacLennan PA; Locke JE
    Am J Transplant; 2018 Oct; 18(10):2483-2495. PubMed ID: 30058218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights into the rational use of HCV+ organs worldwide.
    Morales JM; Sawinski D
    Clin Transplant; 2019 Dec; 33(12):e13739. PubMed ID: 31648391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of using kidneys from hepatitis C nucleic acid test-positive donors for transplantation in hepatitis C-negative recipients.
    Kadatz M; Klarenbach S; Gill J; Gill JS
    Am J Transplant; 2018 Oct; 18(10):2457-2464. PubMed ID: 29797402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C genotype change after transplantation utilizing hepatitis C positive donor organs.
    Adekunle R; Jonchhe S; Ravichandran B; Wilson E; Husson J
    Transpl Infect Dis; 2018 Aug; 20(4):e12925. PubMed ID: 29797655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct-acting antiviral agent-based regimen for HCV recurrence after combined liver-kidney transplantation: Results from the ANRS CO23 CUPILT study.
    Dharancy S; Coilly A; Fougerou-Leurent C; Duvoux C; Kamar N; Leroy V; Tran A; Houssel-Debry P; Canva V; Moreno C; Conti F; Dumortier J; Di Martino V; Radenne S; De Ledinghen V; D'Alteroche L; Silvain C; Besch C; Perré P; Botta-Fridlund D; Francoz C; Habersetzer F; Montialoux H; Abergel A; Debette-Gratien M; Rohel A; Rossignol E; Samuel D; Duclos-Vallée JC; Pageaux GP;
    Am J Transplant; 2017 Nov; 17(11):2869-2878. PubMed ID: 28898563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of hepatitis C-positive donor kidney transplantation for hepatitis C-negative recipients with concomitant direct-acting antiviral therapy.
    Gupta G; Zhang Y; Carroll NV; Sterling RK
    Am J Transplant; 2018 Oct; 18(10):2496-2505. PubMed ID: 30075489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanding access to transplantation with hepatitis C-positive donors: A new perspective on an old issue.
    Kling CE; Limaye AP; Landis CS; Sibulesky L
    Clin Transplant; 2017 Feb; 31(2):. PubMed ID: 28130837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of donor-derived hepatitis C viral infection in three transplant recipients from a donor at increased risk for bloodborne pathogens.
    Shah AP; Cameron A; Singh P; Frank AM; Fenkel JM
    Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28060446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in Utilization and Discard of Hepatitis C-Infected Donor Livers in the Recent Era.
    Bowring MG; Kucirka LM; Massie AB; Luo X; Cameron A; Sulkowski M; Rakestraw K; Gurakar A; Kuo I; Segev DL; Durand CM
    Am J Transplant; 2017 Feb; 17(2):519-527. PubMed ID: 27456927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C transmission from seropositive, nonviremic donors to non-hepatitis C liver transplant recipients.
    Bari K; Luckett K; Kaiser T; Diwan T; Cuffy M; Schoech MR; Safdar K; Blackard JT; Apewokin S; Paterno F; Sherman KE; Zucker SD; Anwar N; Shah SA
    Hepatology; 2018 May; 67(5):1673-1682. PubMed ID: 29205441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilization of hepatitis C virus RNA-positive donor liver for transplant to hepatitis C virus RNA-negative recipient.
    Saberi B; Hamilton JP; Durand CM; Li Z; Philosophe B; Cameron AM; Sulkowski MS; Gurakar A
    Liver Transpl; 2018 Jan; 24(1):140-143. PubMed ID: 28779557
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.